cladribine has been researched along with Leukemia L 1210 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciesielska, E; Robak, T; Szmigielska-Kaplon, A; Szmigiero, L | 1 |
| Góra-Tybor, J; Grieb, P; Robak, T; Warzocha, K | 1 |
| Góra-Tybor, J; Robak, T | 3 |
| Cory, AH; Cory, JG; Nelson, TO; Somerville, L | 1 |
| Fabianowska-Majewska, K; Wyczechowska, D | 1 |
| Marañda, E; Robak, T; Szmigielska, A | 1 |
| Robak, T; Szmigielska, A | 1 |
| Belt, JA; Crawford, CR; Ng, CY | 1 |
| Ashmun, RA; Avery, TL; Blakley, RL; Huang, MC; Kuehl, M | 1 |
| Avery, TL; Blakley, RL; Harwood, FC; Lumm, WC; Rehg, JE; Santana, VM | 1 |
1 review(s) available for cladribine and Leukemia L 1210
| Article | Year |
|---|---|
[Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
Topics: Animals; Antineoplastic Agents; Cladribine; Humans; Leukemia L1210; Leukemia, Hairy Cell; Lymphoproliferative Disorders | 1996 |
11 other study(ies) available for cladribine and Leukemia L 1210
| Article | Year |
|---|---|
Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cladribine; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Mice; Mitoxantrone; Survival Analysis; Time Factors; Tumor Cells, Cultured | 2002 |
Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Leukemia L1210; Methotrexate; Mice; Mice, Inbred DBA; Neoplasm Transplantation | 1994 |
The influence of 2-chlorodeoxyadenosine (2-CdA) alone and in combination with cyclophosphamide or methotrexate on normal and leukemic hematopoiesis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cladribine; Cyclophosphamide; Hematopoiesis; Humans; Leukemia L1210; Leukemia P388; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Mice | 1994 |
Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Drug Synergism; Female; Leukemia L1210; Leukemia P388; Methotrexate; Mice; Mice, Inbred DBA | 1993 |
Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosine.
Topics: Animals; Cell Division; Cladribine; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Deoxyguanosine; Drug Resistance, Neoplasm; Kinetics; Leukemia L1210; Mice; Phosphotransferases (Alcohol Group Acceptor); Tumor Cells, Cultured | 1997 |
Does 2-chlorodeoxyadenosine contribute to alteration of DNA methyltransferase activity?
Topics: Adenosylhomocysteinase; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cladribine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; Hydrolases; Kinetics; Leukemia L1210; Mice; Tumor Cells, Cultured; Vidarabine | 1998 |
Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice | 1999 |
Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Dexamethasone; Disease Models, Animal; Drug Interactions; Leukemia L1210; Leukemia P388; Male; Mice; Neoplasm Transplantation; Treatment Outcome | 2000 |
Isolation and characterization of an L1210 cell line retaining the sodium-dependent carrier cif as its sole nucleoside transport activity.
Topics: 2-Chloroadenosine; Affinity Labels; Animals; Carrier Proteins; Cell Division; Cell Membrane; Cell Survival; Cladribine; Deoxyadenosines; Kinetics; Leukemia L1210; Membrane Transport Proteins; Methotrexate; Mice; Mutation; Nucleosides; Sodium; Thioinosine; Thymidine; Tumor Cells, Cultured | 1990 |
Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Cycle; Cell Line; Cell Survival; Cladribine; Deoxyadenosines; DNA; Humans; Leukemia L1210; Lymphocytes; Protein Biosynthesis; RNA | 1986 |
Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biotransformation; Brain Neoplasms; Cell Division; Cell Line; Chromatography, High Pressure Liquid; Cladribine; Deoxyadenosines; Female; Hematopoietic Stem Cells; Humans; Leukemia L1210; Mice; Mice, Inbred Strains; T-Lymphocytes; Tumor Cells, Cultured | 1989 |